This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Holzapfel, H.-P. Articles by Paschke, R. Search for Related Content PubMed PubMed Citation Articles by Holzapfel, H.-P. Articles by Paschke, R.

Identification of Constitutively Activating Somatic Thyrotropin Receptor Mutations in a Subset of Toxic Multinodular Goiters¹

Department of Internal Medicine III, University of Leipzig (H.-P.H., D.F., P.W., W.A.S., R.P.), D-04103 Leipzig; and the Department of Surgery, Israelitisches Krankenhaus Hamburg (G.W.), Hamburg, Germany

Address all correspondence and requests for reprints to: Prof. Dr. R. Paschke, Department of Internal Medicine III, University of Leipzig, Ph.-Rosenthal-Strasse 27, D-04103 Leipzig, Germany.

Constitutively activating mutations in the TSH receptor (TSHR) gene and in the G_s gene are frequent molecular causes for solitary toxic nodules of the thyroid. However, the etiology of toxic multinodular goiter is still largely unknown. Therefore, DNA from nodular and quiescent surrounding tissue of six patients with toxic multinodular goiters was screened for mutations in exons 9 and 10 of the TSHR gene and exons 7–10 of the G_s gene by direct automated sequencing.

In one patient, two different somatic TSHR mutations were identified in two different toxic nodules (L632I and F631L). In another patient, two different toxic nodules harbored the same TSHR mutation (I630L), whereas only one TSHR mutation (F631L) was identified in one of the two toxic nodules of an additional patient. In the other three patients, no mutations could be found in exons 9 and 10 of the TSHR gene or in exons 7–10 of the G_s gene.

Our results demonstrate that not only solitary toxic adenomas but also toxic multinodular goiters can be caused by constitutively activating mutations of the TSHR. In addition to mutations in the TSHR and possibly in G_s, there are probably other still unknown mechanisms that cause hot nodules in toxic multinodular goiters.

This article has been cited by other articles:

				G. Kleinau and G. Krause Thyrotropin and Homologous Glycoprotein Hormone Receptors: Structural and Functional Aspects of Extracellular Signaling Mechanisms Endocr. Rev., April 1, 2009; 30(2): 133 - 151. [Abstract] [Full Text] [PDF]

				F Palos-Paz, O Perez-Guerra, J Cameselle-Teijeiro, C Rueda-Chimeno, F Barreiro-Morandeira, J Lado-Abeal, the Galician Group for the Study of Toxic Multinod, D Araujo Vilar, R Argueso, O Barca, et al. Prevalence of mutations in TSHR, GNAS, PRKAR1A and RAS genes in a large series of toxic thyroid adenomas from Galicia, an iodine-deficient area in NW Spain Eur. J. Endocrinol., November 1, 2008; 159(5): 623 - 631. [Abstract] [Full Text] [PDF]

				M. Eszlinger, K. Krohn, S. Hauptmann, H. Dralle, T. J. Giordano, and R. Paschke Perspectives for Improved and More Accurate Classification of Thyroid Epithelial Tumors J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3286 - 3294. [Abstract] [Full Text] [PDF]

				H. I. Gozu, R. Bircan, K. Krohn, S. Muller, S. Vural, C. Gezen, H. Sargin, D. Yavuzer, M. Sargin, B. Cirakoglu, et al. Similar prevalence of somatic TSH receptor and Gs{alpha} mutations in toxic thyroid nodules in geographical regions with different iodine supply in Turkey. Eur. J. Endocrinol., October 1, 2006; 155(4): 535 - 545. [Abstract] [Full Text] [PDF]

				S G Watson, A D Radford, A Kipar, P Ibarrola, and L Blackwood Somatic mutations of the thyroid-stimulating hormone receptor gene in feline hyperthyroidism: parallels with human hyperthyroidism J. Endocrinol., September 1, 2005; 186(3): 523 - 537. [Abstract] [Full Text] [PDF]

				F Al-Khafaji, M Wiltshire, D Fuhrer, G Mazziotti, M D Lewis, P J Smith, and M Ludgate Biological activity of activating thyrotrophin receptor mutants: modulation by iodide J. Mol. Endocrinol., February 1, 2005; 34(1): 209 - 220. [Abstract] [Full Text] [PDF]

				V. Vlaeminck-Guillem, S.-C. Ho, P. Rodien, G. Vassart, and S. Costagliola Activation of the cAMP Pathway by the TSH Receptor Involves Switching of the Ectodomain from a Tethered Inverse Agonist to an Agonist Mol. Endocrinol., April 1, 2002; 16(4): 736 - 746. [Abstract] [Full Text] [PDF]

				K. Krohn and R. Paschke Progress in Understanding the Etiology of Thyroid Autonomy J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3336 - 3345. [Full Text] [PDF]

				M. Tonacchera and A. Pinchera Thyrotropin Receptor Polymorphisms and Thyroid Diseases J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2637 - 2639. [Full Text]

				T. Mühlberg, K. Herrmann, W. Joba, M. Kirchberger, H.-J. Heberling, and A. E. Heufelder Lack of Association of Nonautoimmune Hyperfunctioning Thyroid Disorders and a Germline Polymorphism of Codon 727 of the Human Thyrotropin Receptor in a European Caucasian Population J. Clin. Endocrinol. Metab., August 1, 2000; 85(8): 2640 - 2643. [Abstract] [Full Text]

				M. Tonacchera, P. Agretti, L. Chiovato, V. Rosellini, G. Ceccarini, A. Perri, P. Viacava, A. G. Naccarato, P. Miccoli, A. Pinchera, et al. Activating Thyrotropin Receptor Mutations Are Present in Nonadenomatous Hyperfunctioning Nodules of Toxic or Autonomous Multinodular Goiter J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2270 - 2274. [Abstract] [Full Text]

				A. Lienhardt, M. Garabédian, M. Bai, C. Sinding, Z. Zhang, J.-P. Lagarde, J. Boulesteix, M. Rigaud, E. M. Brown, and M.-L. Kottler A Large Homozygous or Heterozygous In-Frame Deletion within the Calcium-Sensing Receptor's Carboxylterminal Cytoplasmic Tail That Causes Autosomal Dominant Hypocalcemia J. Clin. Endocrinol. Metab., April 1, 2000; 85(4): 1695 - 1702. [Abstract] [Full Text]